Live feed16:02:16·97dINSIDERFilingChief Financial Officer Adawi Kamal was granted 25,000 shares, increasing direct ownership by 33% to 100,000 units (SEC Form 4)FATE· Fate Therapeutics Inc.Health CareOriginal source